

UMass Medical School develops ‘paraprobiotic’ to fight parasitic roundworms in humans
Raffi Van Aroian, PhD, and Gary R. Ostroff, PhD, and colleagues are developing an engineered bacterium that can be used to safely treat hookworms in animal models and is a potential therapeutic against the parasitic worm in humans.
Read moreResearch


Atalanta Therapeutics founded by UMass Medical School and three faculty members
Atalanta Therapeutics, a biotech founded by UMass Medical School and three faculty research scientists to pioneer treatment options for neurodegenerative diseases, has launched with financing by venture capital fund F-Prime Capital and strategic collaborations with Biogen and Genentech.
Read moreEducation


Student-led virtual wellness program provides companionship to older, hospitalized COVID patients
A new companionship wellness initiative at UMass Medical School is combating isolation and loneliness among COVID-19 patients 65 and older by having students virtually check in, comfort and emotionally support them at two Worcester hospitals.
Read moreCommunity


Chancellor Collins and President Meehan call for COVID-19 Vaccine Corps in Boston Globe op-ed
UMass Medical School Chancellor Michael F. Collins and UMass President Marty Meehan are calling for the creation of a national COVID-19 Vaccine Corps, in a Boston Globe op/ed published Friday, Jan. 1.
Read more